News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
1419
Sources here
17
Companies here
26
Search results Stored financial headlines

Active search

1419 matching headlines

Ticker or company: ESIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Design Therapeutics, Inc. $DSGN Shares Purchased by Sei Investments Co.

Sei Investments Co. significantly increased its stake in Design Therapeutics, Inc. (NASDAQ:DSGN) by 152.6% in the first quarter, now holding 133,203 shares valued at approximately $1.42 million. Institutional investors collectively own 56.64% of the company. Despite reporting a quarterly EPS of negative $0.32, beating …

DSGN main company
Sharemaestro market context Trend signal active 52 weeks +181.9% · Next-week setup positive 55.7% DSGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resideo (REZI) Q2 Earnings Report Preview: What To Look For

Resideo (REZI) is set to report its Q2 earnings this Wednesday after the bell. The market anticipates flat year-on-year revenue for Resideo, a slowdown from the previous year's 22.3% increase. While the building materials segment has seen positive investor sentiment recently, Resideo's stock is …

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit, filed on behalf of investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, alleges that the company made materially false …

PHR main company
Sharemaestro market context Price above Trend Line 52 weeks -58.7% PHR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ

Organogenesis Holdings, Inc. Class A (MUN:2PQ) generated €479.37 million in revenue last year, primarily from its Advanced Wound Care segment, which contributed €452.31 million. The majority of this revenue, €479.37 million, originated from the United States market. These figures represent an increase from the …

ORGO main company
Sharemaestro market context Price below Trend Line 52 weeks -63.4% ORGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cadence Design Systems Inc. stock underperforms Monday when compared to competitors

Cadence Design Systems Inc. (CDNS) stock fell 2.16% on Monday, underperforming the broader market. This drop occurred despite the S&P 500 Index and Dow Jones Industrial Average experiencing only slight declines. The stock's fall ended a two-day winning streak.

CDNS main company
Sharemaestro market context Trend signal active 52 weeks -7.1% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HC Wainwright Forecasts Biodesix's Q3 Earnings (NASDAQ:BDSX)

HC Wainwright has updated its Q3 2026 EPS estimates for Biodesix (NASDAQ:BDSX), lowering it to a loss of $0.75 per share, while maintaining a "Buy" rating and a $27 price target. This follows Biodesix's recent Q2 earnings report where the company surpassed analyst expectations, …

BDSX main company
Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8% BDSX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Chartwell Retirement Residences (TSX:CSH.UN) Stock Looks Stretched Despite Strong Q2 Results

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Chartwell Retirement Residences has delivered a strong 135.2% return over the past three years, yet its current checks suggest the stock now leans expensive …

CSH-UN main company
Sharemaestro market context Trend signal active 52 weeks +16.6% · Next-week setup positive 55.6% CSH-UN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in NexPoint Residential Trust, Inc. Stocks

This article lists various ETFs that include NexPoint Residential Trust, Inc. (A14QBV) stocks in their holdings. The ETFs are sorted by market value and provide details such as issuer, management style, focus, expense ratio, and AUM, making it easier for investors to explore diversified …

NXRT main company
Sharemaestro market context Price below Trend Line 52 weeks -21.4% NXRT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BDSX Maintained by Canaccord Genuity -- Price Target Raised to $35

Canaccord Genuity has maintained a 'Buy' rating for Biodesix (BDSX) and increased its price target from $27.00 to $35.00, indicating strong confidence in the company's future. While analysts are optimistic about Biodesix's growth, particularly in medical diagnostics, the stock is considered modestly overvalued according …

BDSX main company
Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8% BDSX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price

Canaccord Genuity Group has increased its price target for Biodesix (NASDAQ:BDSX) to $35 from $27, maintaining a "buy" rating and implying a significant upside of 48.94%. This positive forecast aligns with a "Moderate Buy" consensus rating from other analysts, supported by the company's recent …

BDSX main company
Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8% BDSX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Canaccord raises Biodesix stock price target on strong test volume

Canaccord has increased its price target for Biodesix Inc. (NASDAQ:BDSX) to $35 from $27, maintaining a Buy rating, due to higher revenue projections for 2026 and beyond. This adjustment follows Biodesix's strong second-quarter 2026 results, which surpassed estimates, driven by increased Nodify test volume …

BDSX main company
Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8% BDSX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cartesian Therapeutics Advances RNA Cell Therapy Pipeline; Wedbush Sets $38 Price Target

Cartesian Therapeutics (RNAC) is advancing its RNA cell therapy pipeline, with its lead candidate, Descartes-08, an autologous RNA CAR-T therapy, holding significant potential for autoimmune diseases. Wedbush has set a price target of $38 for the company. The therapy has received FDA RMAT, Fast …

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GEL Q2 Deep Dive: Balance Sheet Progress and Offshore Asset Strategy Drive Results

GEL Q2 Deep Dive: Balance Sheet Progress and Offshore Asset Strategy Drive Results Midstream energy infrastructure company Genesis Energy (NYSE:GEL) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 41% year on year to $532 million. Its GAAP profit of …

GEL main company
Sharemaestro market context Price below Trend Line 52 weeks -4.6% · Next-week setup positive 61.1% GEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NexPoint Residential Trust, Inc. (NYSE:NXRT) Receives Average Rating of "Hold" from Brokerages

NexPoint Residential Trust (NYSE:NXRT) has received an average "Hold" rating from five analysts, with a mix of sell, hold, and strong-buy recommendations, and an average 12-month price target of $22.00. The company reported better-than-expected quarterly EPS of -$0.34 and revenue of $64.61 million, though …

NXRT main company
Sharemaestro market context Price below Trend Line 52 weeks -21.4% NXRT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Research Analysts Offer Predictions for CDNS FY2026 Earnings

Erste Group Bank has increased its FY2026 EPS forecast for Cadence Design Systems (CDNS) to $6.39, aligning closely with the consensus estimate. The company recently surpassed Q2 expectations with an EPS of $2.11 and revenue of $1.58 billion, and has provided strong FY2026 EPS …

CDNS main company CDNS main company
Sharemaestro market context Trend signal active 52 weeks -14.3% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensign Energy Services Q2 Earnings Call Highlights

Ensign Energy Services (TSE:ESI) reported higher second-quarter revenue and adjusted EBITDA as operating activity increased across Canada, the United States and international markets, while the company continued to reduce debt and prepared to close its acquisition of Citadel Drilling Ltd. Revenue for the second …

ESI main company
Sharemaestro market context Price above Trend Line 52 weeks +66.5% ESI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Chartwell Retirement Residences Q2 Earnings Call Highlights

Key Points Interested in Chartwell Retirement Residences? Here are five stocks we like better. Strong Q2 operating performance: Funds from operations rose 34% year over year to $90.5 million, while FFO per unit increased 17% to $0.28. Same-property occupancy improved 320 basis points to …

CSH-UN main company
Sharemaestro market context Trend signal active 52 weeks +16.6% · Next-week setup positive 55.6% CSH-UN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Telkom Indonesia (Persero) Tbk PT (TLK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Telkom Indonesia (Persero) Tbk PT (TLK), highlighting its strong earnings forecast score of 10.00 and ranking 1st in the Telecommunications Services industry. Analysts have set an average price target of $24.10, with one analyst recommending a "Strong …

TLK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.3% · Next-week setup positive 55.6% TLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context